<DOC>
	<DOCNO>NCT00906022</DOCNO>
	<brief_summary>The clinical investigation prospective , international , multi-centre , randomize ( 1:1 ) trial follow investigation 1 , 3 , 6 12 month . Patients randomize either treatment stenting Astron Pulsar SE ( 4 5 mm diameter ) stent PTA optional bailout stenting case PTA failure . The primary objective study show clinical improvement outcome patient symptomatic critical limb ischemia severe intermittent claudication ( Rutherford 3 , 4 , 5 ) treat Astron Pulsar SE ( 4 5 mm diameter ) comparison PTA optional bailout stenting case PTA failure .</brief_summary>
	<brief_title>Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty ( PTA ) With Optional Bailout Stenting Case PTA Failure Patients With Symptomatic Critical Limb Ischemia Severe Intermittent Claudication ( EXPAND )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>1 . Age &gt; 50 year 2 . Patient sign patient inform consent . 3 . Patient willing adhere follow time point follow requirement study 4 . Patient symptomatic critical limb ischemia severe intermittent claudication classify Rutherford category 3 , 4 5 . 5 . Stenotic ( &gt; 50 % ) occlusive atherosclerotic disease infrapopliteal artery radiographic level knee joint level ankle ( include peroneotibial trunk , anterior tibial artery , posterior tibial artery peroneal artery , exclude popliteal artery ) , determined preprocedure intraarterial DSA ( prefer ) conventional angiography . 6 . Target ( study ) lesion treat de novo lesion ( lesion ≤ 190 mm length ) . NOTE : Multiple diffuse lesion treatment allow long total lesion length ≤ 190 mm ) 7 . Reference vessel diameter 2.5 4.0 mm . 8 . Target vessel : It must possible follow vessel runoff foot and/or wound area . NOTE : Patients incomplete abnormal anatomical runoff NOT exclude . Important see runoff foot and/or wound area even collateral involve . 9 . Haemodynamically significant inflow stenosis vessel knee successfully treat . 10 . Lesions must cross successfully guide wire guide wire must within true lumen distal vessel . Notes : Target vessel define ; Target vessel = vessel target lesion treat Target vessel : Multiple diffuse lesion total length &gt; 190 mm = &gt; inclusion criterion NOT fulfil NONtarget vessel ( ) : haemodynamically significant lesion treat accord investigator 's discretion 1 . Patient refuse treatment . 2 . Patient legally , physically mentally unable give consent . 3 . ABI / TBI measurement impossible . 4 . Target lesion pretreated . 5 . Target lesion lie within adjacent aneurysm . 6 . Acute thrombus present target limb . 7 . The reference vessel diameter suitable available stent size ( RVD &lt; 2.5 &gt; 4.0 mm ) . 8 . Length lesion require one treatment device ( lesion length &gt; 190 mm ) 9 . Hybrid technique ( bypass surgery peripheral intervention PTA stent session ) allow . Note : Allowed patient get P1 P3 bypass previous session possible treat distal lesion bypass separate session . Time window bypass surgery plan intervention must least 30 day . 10 . Lifeexpectancy le 12 month time screen . 11 . Patient know allergy heparin , aspirin , clopidogrel anticoagulant/ antiplatelet therapy , nickel contrast medium unwilling tolerate therapy . 12 . Patient bleeding diatheses 13 . Patient currently enrol another investigational device drug trial . 14 . Patient take part another investigational device drug trial within 3 month prior screen . 15 . Patient currently breastfeed , pregnant intend become pregnant . 16 . Myocardial infarction without coronary revascularization &lt; 6 month prior screen coronary revascularization &lt; 1 month prior screen . 17 . Previous coronary peripheral bypass surgery within 30 day prior screen . 18 . Patient calculate creatinine clearance &lt; 30 ml/min within 30 day prior screen . 19 . Patient stroke TIA within last 6 month prior screen . 20 . Patient major amputation target limb ( defined ankle ) time screen</criteria>
	<gender>All</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Below Knee</keyword>
	<keyword>Infrapopliteal artery</keyword>
	<keyword>nitinol</keyword>
	<keyword>limb ischemia</keyword>
	<keyword>claudication</keyword>
	<keyword>self-expanding stent</keyword>
	<keyword>duplex</keyword>
	<keyword>angiography</keyword>
</DOC>